Stephanie Haller

Promising Prospects for ⁴⁴Sc-/⁴⁷Sc-Based Theragnostics: Application of ⁴⁷Sc for Radionuclide Tumor Therapy in Mice

Cristina Müller, Maruta Bunka, Stephanie Haller et al. · Journal of Nuclear Medicine · 2014 · 213 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate

Cristina Müller, Josefine Reber, Stephanie Haller et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 143 citations · Full text

Medicine, Nuclear Medicine, Oncology +12

Cyclotron production of 44Sc: From bench to bedside

Nicholas P. van der Meulen, Maruta Bunka, Katharina A. Domnanich et al. · Nuclear Medicine and Biology · 2015 · 118 citations

Natural Sciences, Chemistry, Nuclear Chemistry +2

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

Francesca Borgna, Stephanie Haller, Josep M. Monné Rodríguez et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes

Katharina A. Domnanich, Cristina Müller, Martina Benešová et al. · EJNMMI Radiopharmacy and Chemistry · 2017 · 91 citations · Full text

Medicine, Nuclear Medicine, Radiology +17